Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)

China · Delayed Price · Currency is CNY

21.12

-0.38 (-1.77%)

Sep 2, 2026, 4:00 PM EDT

SHE:301584 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	19,437	19,430	17,923	15,443	11,882	10,024
Revenue Growth	7.64%	8.41%	16.05%	29.97%	18.54%	17.35%
Gross Profit	1,487	1,486	1,321	1,179	896.48	685.03
Operating Income	587.37	579.63	541.74	442.8	323.06	261.45
Net Income	285.6	269.63	228.31	196.3	174.28	166.94
Earnings Per Share	0.71	0.71	0.64	0.55	0.49	0.47
EPS Growth	10.50%	10.94%	16.36%	12.25%	4.25%	4.44%

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Direct Selling Business	11,053	11,032	10,056	7,797	7,511
Distribution Business	8,047	6,738	5,283	4,036	2,472
Service Business	285.38	112.39	75.47	33.24	24.66
Unallocated Other	44.14	40.4	-	-	-
Total	19,430	17,923	15,414	11,867	10,008

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,598	1,927	1,788	1,487	1,051	577.97
Total Debt	3,535	3,588	4,044	3,661	2,552	1,323
Net Cash (Debt)	-1,937	-1,661	-2,256	-2,174	-1,501	-744.9
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-4.84	-4.37	-6.32	-6.09	-4.22	-2.10

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	1,021	748.31	164.48	-374.57	-627.89	-732.97
Capital Expenditures	-74.2	-80.71	-121.05	-82.39	-33.5	-10.18
Free Cash Flow	947.04	667.6	43.42	-456.96	-661.39	-743.15
Free Cash Flow Growth	-	1437.49%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	7.65%	7.65%	7.37%	7.64%	7.54%	6.83%
Operating Margin	3.02%	2.98%	3.02%	2.87%	2.72%	2.61%
Pretax Margin	2.50%	2.32%	2.11%	2.04%	2.10%	2.30%
Profit Margin	1.47%	1.39%	1.27%	1.27%	1.47%	1.67%
FCF Margin	4.87%	3.44%	0.24%	-2.96%	-5.57%	-7.41%

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	0.200	0.200
Dividend Per Share Growth	0%	-
Dividend Yield	0.93%	0.69%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	29.62	45.66	-	-	-	-
P/FCF Ratio	9.40	18.44	-	-	-	-
PS Ratio	0.46	0.63	-	-	-	-